Aim: to produce unique products with novel properties, to manipulate materials at the nano-
scale level. Nanoparticles demonstrate novel or improved characteristics which are …

This study attempted to scrutinize the potential efficacy of zinc oxide nanoparticles (ZnONPs)
and the standard oral hypoglycemic drug glibenclamide in streptozotocin (STZ) …

The use of nanoparticles in medicine is an attractive proposition. In the present study, zinc
oxide and silver nanoparticles were evaluated for their antidiabetic activity. Fifty male albino …

Aim: The correlation of diabetes and an imbalance in zinc homeostasis makes zinc-based
therapy an attractive proposition. In this study, zinc oxide nanoparticles were evaluated for …

In the present study, Zinc oxide nanoparticles andSilver Oxide nanoparticles were evaluated
for their in vivo and in vitro antidiabetic activity. The resulting ZnO, Ag 2 O were …

This study evaluated the biochemical, molecular, and histopathological mechanisms
involved in the hypoglycaemic effect of zinc oxide nanoparticles (ZnONPs) in experimental …

Diabetes mellitus (DM) is a metabolic disorder with numerous secondary complications.
Herein, the effect of zinc oxide-nanoparticles (ZnO-NPs), zinc sulfate-traditional form (ZnSO …

The antidiabetic, hypoglycemic and oral glucose tolerance test (OGTT) activities of zinc
oxide nanoparticles (ZnONPs) were assessed in mice. ZnONPs were prepared by reacting …

In the current study, antidiabetic activity and toxic effects of zinc oxide nanoparticles (ZnO)
were investigated in diabetic rats compared to zinc sulfate (ZnSO 4) with particular emphasis …

Different studies in experimental diabetes models suggest that zinc oxide nanoparticles
(ZnONPs) are useful as antidiabetic agents. However, this evidence was performed and …